ArticleJAAD international2023

Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the interleukin-23 inhibitor class.

Ahmed Bagit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.